https://biotechmorning.com/news/parse-biosciences-patent-verdict-single-cell-sequencing Biotech Morning en 2026-09-01T14:15:18.981Z A $4.8M Verdict That Could Redraw the Single-Cell Sequencing Map https://biotechmorning.com/news/oral-relaxin-heart-failure-comeback Biotech Morning en 2026-09-01T14:14:30.850Z The Heart Failure Drug That Keeps Coming Back From the Dead https://biotechmorning.com/news/car-t-autoimmune-safety-crisis-novartis-bms Biotech Morning en 2026-09-01T14:13:38.927Z CAR-T's Worst Week Just Threatened Its Most Exciting Frontier https://biotechmorning.com/news/fda-commissioner-kalvista-drug-rejection-staff-pushback Biotech Morning en 2026-09-01T14:12:57.183Z The FDA Commissioner Tried to Kill a Drug Approval. His Own Staff Said No. https://biotechmorning.com/news/sanofi-backed-electra-nasdaq-ipo-filing Biotech Morning en 2026-09-01T14:12:12.622Z Sanofi's Secret Weapon Just Filed to Go Public https://biotechmorning.com/news/drug-pricing-squeeze-midsize-biotech Biotech Morning en 2026-09-01T14:11:30.571Z The Drug Pricing Squeeze Just Moved Down the Food Chain https://biotechmorning.com/news/samsung-biologics-polypeptide-group-takeover Biotech Morning en 2026-09-01T14:10:47.062Z Samsung Biologics Just Bet $1.8B That Peptides Are the Future https://biotechmorning.com/news/gsk-mrna-flu-vaccine-phase-3 Biotech Morning en 2026-09-01T14:10:01.140Z GSK's Flu Shot Just Beat the Old Guard. Now Comes the Hard Part. https://biotechmorning.com/news/tagrisso-orpathys-egfr-lung-cancer-combo Biotech Morning en 2026-09-01T14:09:17.376Z Tagrisso's $6 Billion Fortress Just Got a New Weapon https://biotechmorning.com/news/perfuze-stroke-catheter-marrs-trial-results Biotech Morning en 2026-08-31T14:14:20.863Z The Stroke Catheter That Barely Needs a Second Try https://biotechmorning.com/news/genentech-hanmi-hm17321-obesity-deal Biotech Morning en 2026-08-31T14:13:38.932Z Genentech Just Paid $2.3B for a Drug That Builds Muscle While You Lose Weight https://biotechmorning.com/news/sarepta-gene-therapy-black-box-warning-layoffs Biotech Morning en 2026-08-31T14:12:50.666Z Sarepta's Gene Therapy Just Got the Scariest Label in Medicine https://biotechmorning.com/news/claude-ai-designed-protein-binders-validated Biotech Morning en 2026-08-31T14:12:06.689Z Claude Just Designed 1,320 Proteins. Most of Them Actually Worked. https://biotechmorning.com/news/lilly-merida-autoantibody-degradation-deal Biotech Morning en 2026-08-31T14:11:19.720Z Lilly Just Spent $2.88 Billion to Teach Your Body to Eat Its Own Antibodies https://biotechmorning.com/news/first-new-et-treatment-30-years-besremi Biotech Morning en 2026-08-31T14:10:31.378Z The First New Blood Cancer Drug in 30 Years Just Got the Green Light https://biotechmorning.com/news/ascendis-biomarin-yuviwel-patent-settlement Biotech Morning en 2026-08-31T14:09:48.857Z The $2 Billion Handshake That Ends Biotech's Nastiest Patent Fight